印度应对COVID-19大流行的挑战与成功。

IF 3.1 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Research and Reports in Tropical Medicine Pub Date : 2021-08-14 eCollection Date: 2021-01-01 DOI:10.2147/RRTM.S274673
Juhi Sharma, Divakar Sharma, Dileep Tiwari, Vaishali Vishwakarma
{"title":"印度应对COVID-19大流行的挑战与成功。","authors":"Juhi Sharma,&nbsp;Divakar Sharma,&nbsp;Dileep Tiwari,&nbsp;Vaishali Vishwakarma","doi":"10.2147/RRTM.S274673","DOIUrl":null,"url":null,"abstract":"<p><p>As the infectivity of the SARS-CoV-2 virus is higher compared with other coronaviruses reported so far, so effective therapeutics and vaccines are the best way to control the proliferation of this infection The COVID-19 mortality rate is lower compared with other similar viral diseases such as severe acute respiratory Ssndrome (SARS) and Middle East respiratory syndrome (MERS). However, due to the evolution of SARS-CoV-2 mutants that are responsible for the subsequent waves, mortality due to COVID-19 has increased across the globe. Currently, the magnitude of SARS-CoV-2 infection is highly severe and is leading to a tremendously increased number of deaths globally. Scientists expect that SARS-CoV-2 has the potential to become a seasonal disease like influenza and may persist with humanity in the future. Currently, preventive strategies such as sanitation, social distancing, use of masks, potential chemotherapies (pathogen-centric and host-centric), and vaccines are the only option to fight against COVID-19. Many groups of Indian government-public private consortia had set up different strategies (development of multiple vaccines) for combat of this unique threat through stepssuch as an increase in vaccinations and sample testing per day. In this focused review, we have discussed the challenges faced and success stories employed to manage COVID-19.</p>","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2021-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/04/0d/rrtm-12-205.PMC8374532.pdf","citationCount":"3","resultStr":"{\"title\":\"The Challenges and Successes of Dealing with the COVID-19 Pandemic in India.\",\"authors\":\"Juhi Sharma,&nbsp;Divakar Sharma,&nbsp;Dileep Tiwari,&nbsp;Vaishali Vishwakarma\",\"doi\":\"10.2147/RRTM.S274673\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>As the infectivity of the SARS-CoV-2 virus is higher compared with other coronaviruses reported so far, so effective therapeutics and vaccines are the best way to control the proliferation of this infection The COVID-19 mortality rate is lower compared with other similar viral diseases such as severe acute respiratory Ssndrome (SARS) and Middle East respiratory syndrome (MERS). However, due to the evolution of SARS-CoV-2 mutants that are responsible for the subsequent waves, mortality due to COVID-19 has increased across the globe. Currently, the magnitude of SARS-CoV-2 infection is highly severe and is leading to a tremendously increased number of deaths globally. Scientists expect that SARS-CoV-2 has the potential to become a seasonal disease like influenza and may persist with humanity in the future. Currently, preventive strategies such as sanitation, social distancing, use of masks, potential chemotherapies (pathogen-centric and host-centric), and vaccines are the only option to fight against COVID-19. Many groups of Indian government-public private consortia had set up different strategies (development of multiple vaccines) for combat of this unique threat through stepssuch as an increase in vaccinations and sample testing per day. In this focused review, we have discussed the challenges faced and success stories employed to manage COVID-19.</p>\",\"PeriodicalId\":21138,\"journal\":{\"name\":\"Research and Reports in Tropical Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2021-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/04/0d/rrtm-12-205.PMC8374532.pdf\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Research and Reports in Tropical Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/RRTM.S274673\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research and Reports in Tropical Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/RRTM.S274673","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 3

摘要

由于SARS- cov -2病毒的传染性高于迄今报道的其他冠状病毒,因此有效的治疗和疫苗是控制这种感染扩散的最佳途径。与其他类似的病毒性疾病如严重急性呼吸综合征(SARS)和中东呼吸综合征(MERS)相比,COVID-19的死亡率较低。然而,由于导致随后浪潮的SARS-CoV-2突变体的进化,全球因COVID-19导致的死亡率有所上升。目前,SARS-CoV-2感染的程度非常严重,正在导致全球死亡人数大幅增加。科学家们预计,SARS-CoV-2有可能成为像流感一样的季节性疾病,并可能在未来持续存在于人类身上。目前,卫生、保持社交距离、使用口罩、可能的化疗(以病原体为中心和以宿主为中心)以及疫苗等预防策略是抗击COVID-19的唯一选择。印度政府-公共-私营财团的许多团体制定了不同的战略(开发多种疫苗),通过增加疫苗接种和每天进行样本检测等步骤来对付这一独特的威胁。在这次重点审查中,我们讨论了应对COVID-19面临的挑战和成功案例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The Challenges and Successes of Dealing with the COVID-19 Pandemic in India.

The Challenges and Successes of Dealing with the COVID-19 Pandemic in India.

As the infectivity of the SARS-CoV-2 virus is higher compared with other coronaviruses reported so far, so effective therapeutics and vaccines are the best way to control the proliferation of this infection The COVID-19 mortality rate is lower compared with other similar viral diseases such as severe acute respiratory Ssndrome (SARS) and Middle East respiratory syndrome (MERS). However, due to the evolution of SARS-CoV-2 mutants that are responsible for the subsequent waves, mortality due to COVID-19 has increased across the globe. Currently, the magnitude of SARS-CoV-2 infection is highly severe and is leading to a tremendously increased number of deaths globally. Scientists expect that SARS-CoV-2 has the potential to become a seasonal disease like influenza and may persist with humanity in the future. Currently, preventive strategies such as sanitation, social distancing, use of masks, potential chemotherapies (pathogen-centric and host-centric), and vaccines are the only option to fight against COVID-19. Many groups of Indian government-public private consortia had set up different strategies (development of multiple vaccines) for combat of this unique threat through stepssuch as an increase in vaccinations and sample testing per day. In this focused review, we have discussed the challenges faced and success stories employed to manage COVID-19.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Research and Reports in Tropical Medicine
Research and Reports in Tropical Medicine MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
0.00%
发文量
7
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信